clinical trials

Abbott Launches New Initiative to Drive Diversity in Medical Research and Improve Care Among Under-Represented Populations

Summary: 
  • Abbott is addressing a key challenge to health equity by putting a greater focus on breaking down the barriers to clinical trial participation for under-represented groups
  • Company has dedicated $5 million for nearly 300 new scholarships over the next five years at medical schools at historically black colleges and universities (HBCUs) and minority nursing associations to support future generations of diverse clinical investigators
  • The company has also formed a new Diversity in Research Medical Advisory Board and dedicated funding to increase diversity enrollment within Abbott trials
  • The latest initiative is another step to support the work the company and its foundation, the Abbott Fund, are doing to reduce health disparities around the world
Press Release
  • Abbott is addressing a key challenge to health equity by putting a greater focus on breaking down the barriers to clinical trial participation for under-represented groups
  • Company has dedicated $5 million for nearly 300 new scholarships over the next five years at medical schools at historically black colleges and universities (HBCUs) and minority nursing associations to support future generations of diverse clinical investigators
  • The company has also formed a new Diversity in Research Medical Advisory Board and dedicated funding to increase diversity enrollment within Abbott trials
  • The latest initiative is another step to support the work the company and its foundation, the Abbott Fund, are doing to reduce health disparities around the world

Committing to Our Clinical Trial Communities

Expanding clinical trial diversity, education and resources to aid science and people.
Blog

Clinical trials are a vital part of the process that brings innovative products and treatments to people in need. No matter the disease or condition, the overarching goal remains the same:

Provide the best care options to all people in need.

However, the unfortunate fact is that racial and ethnic groups have long been underrepresented in clinical trials.

COVID-19 Therapeutics Accelerator Awards $20 Million in Initial Grants to Fund Clinical Trials

Researchers at three institutions in the U.S. and U.K. receive grants to advance studies of repurposed drugs and novel antibodies in preventing COVID-19
Press Release

PURCHASE, NY – March 31, 2020 /3BL Media/ – The partners in the COVID-19 Therapeutics Accelerator have announced grants of $20 million to three institutions—the University of Washington, University of Oxford, and La Jolla Institute for Immunology—to fund clinical trials in order to identify highly potent immunotherapies for the COVID-19 pandemic.

Shire Commitments to Support Patients as Part of Responsibility Strategy

Article

At Shire, supporting patients is at the heart of being a champion for patients. Beyond discovering and developing medicines, we are committed to dramatically shortening the time to diagnosis for rare diseases, and we aim to support patients along the entire patient journey, from conducting clinical trials to enabling patients to better manage their care through the use of innovative digital technologies, and beyond.

What Would a Pharmacy Look Like Without Clinical Trials? Here's a Hint - Empty.

Article

While there are thousands of experimental drugs currently in development, with the potential to ease symptoms or even cure various diseases, none of these treatments will become available to patients without clinical trials and clinical trial volunteers. In a global study conducted by The Center for Information and Study on Clinical Research Participation (CISCRP) a non-profit-organization, in 2017, close to 70% of the public has never or rarely considered clinical trials as an option when discussing treatment options with their doctor or health provider.

CISCRP’s New Clinical Research Awareness Initiative Uses Empty Pharmacy Shelves to Educate Public and Patients

by Ari Roul, Chicago Evening Post
Article

The Center for Information and Study on Clinical Research Participation has released a new educational video. Sponsored by Sanofi US, the digital public service announcement is designed to increase awareness of the important role that clinical research participants and clinical trials play in advancing public health.

The Possibility Report: Healing Bodies and Environments with Technology

Article

The third theme in The Possibility Report series, HEAL looks into the innovative ways we can use technology to heal individual bodies as well as the planet as a whole.

Why We Should Bring Coral Reefs Online

A New Way to Approach and Experience Medical Care

LIVESTRONG and Eli Lilly and Company Honor Clinical Trials Participants

Lilly-commissioned art installation by renowned sculptor and clinical trial community to debut at LIVESTRONG
Press Release

Austin, Texas, March 6, 2017 /3BL Media/ On March 10, the LIVESTRONG Foundation will host an unveiling reception for The Hero’s Journey Art, an art installation created by sculptor John Magnan in collaboration with Eli Lilly and Company to honor clinical trial participants and raise awareness of the importance of clinical trial participation.

Babak’s Story: Working to Provide Access for ‘Cultures of Need’

Multimedia with summary

Babak immerses himself in his work. As a physician serving patients around the world, he learned more than just how to live and work in remote areas. Living and serving people in neglected communities trained Babak to accommodate the dynamics of isolated, resource-poor populations – cultures of need. His current role leading medical teams, researching new medicines and conducting clinical trials aligns perfectly with his mission to help address areas of significant unmet medical need.

Aparna's Story: Redefining Possibilities for Patients with Rare Diseases

Article

Aparna had only been working as a clinical programmer on Bristol-Myers Squibb’s Global Biometrics Sciences team for six months when five-year-old Tayjus was diagnosed with Duchenne Muscular Dystrophy (DMD). Universal support from managers, co-workers, friends and family has helped her redefine what can be achieved by focusing on one day, and one goal, at a time.

Pages

Subscribe to clinical trials